Comorbidity Management

Clinical Trials and Studies

The Optipharm-CKM Programme

On behalf of the San Raffaele University (uniroma-5), the Italian Heart Failure Association (ITAHFA) and Heart Success Foundation (HFS) The Optipharm Registry focuses on improving care for patients with cardiovascular, kidney, and metabolic conditions (CKM), which are closely linked and…

March 3, 2025
Cardiovascular Outcomes, Comorbidity Management, Guideline-Directed Medical Therapy (GDMT)

Heart Failure Insights

Suspected de novo heart failure in outpatient care: the REVOLUTION HF study

Summary of study: The study aimed to investigate the outcomes, healthcare patterns, and costs related to suspected de novo heart failure (patients experiencing it for the first time). Patients were selected based on presenting with signs or symptoms of HF.…

March 3, 2025
Cardiovascular Outcomes, Comorbidity Management, Heart Failure Treatment, Patient Care Optimization

Comorbidity Management

The Optipharm-CKM Programme

Suspected de novo heart failure in outpatient care: the REVOLUTION HF study

Subscribe to the HSF Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!